NASDAQ: CODXCo Diagnostics Inc Stock
$3.37+0.04 (+1.2%)
Updated Jun 18, 2026
CODX Price
$3.37
Fair Value Price
$7.86
Market Cap
$12.14M
52 Week Low
$1.26
52 Week High
$46.50
P/E
-0.1x
P/B
0.76x
P/S
5.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$718.17k
Earnings
-$48.50M
Gross Margin
45.1%
Operating Margin
-6,980.3%
Profit Margin
-6,753.7%
Debt to Equity
0.34
Operating Cash Flow
-$28M
Beta
1.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CODX Overview
Co-Diagnostics, Inc. (CODX) is a molecular diagnostics company that designs, produces, and globally markets specialized reagents. These components are integral to diagnostic tests that identify and analyze nucleic acid molecules. The company's product portfolio features the Co-Dx PCR platform, enabling Polymerase Chain Reaction (PCR) testing for patients in both clinical (point-of-care) and home settings. They offer an extensive range of PCR diagnostic tests for numerous conditions, including COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. Beyond human health, Co-Diagnostics develops three distinct multiplexed tests for screening mosquitos to detect disease-carrying pathogens. Their advanced molecular tools also serve broader applications, encompassing infectious disease detection, liquid biopsy for cancer screening, and agricultural uses such as identifying genetic traits in plant and animal genomes. Complementing these offerings is a portable diagnostic device, specifically engineered to make PCR testing accessible directly to patients in various settings. The company was founded in 2013 and is based in Salt Lake City, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CODX's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
CODX
Ranked#80 of 93
Ranked#80 of 93
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.71 | A | |
| $38.68 | A | |
| $26.62 | A |
Be the first to know about important CODX news, forecast changes, insider trades & much more!
CODX News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CODX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CODX ($3.37) is undervalued by 57.13% relative to our estimate of its Fair Value price of $7.86 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CODX ($3.37) is significantly undervalued by 57.13% relative to our estimate of its Fair Value price of $7.86 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CODX due diligence checks available for Premium users.
Valuation
CODX fair value
Fair Value of CODX stock based on Discounted Cash Flow (DCF)
Price
$3.37
Fair Value
$7.86
Undervalued by
57.13%
CODX ($3.37) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CODX ($3.37) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CODX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.1x
Industry
20.08x
Market
9.47x
CODX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.76x
Industry
2.95x
CODX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CODX's financial health
Profit margin
Revenue
$146.0k
Net Income
-$9.1M
Profit Margin
-6,262.3%
CODX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CODX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$21.5M
Liabilities
$5.5M
Debt to equity
0.34
CODX's short-term assets ($9.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CODX's short-term assets ($9.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CODX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CODX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$7.8M
Investing
-$142.0k
Financing
$4.3M
CODX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CODX vs Medical Device Stocks
Co Diagnostics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.